Use the therapeutic combination and treatment method of the prodrug of tizoxanide, its analog or salt
WO2012058378A1
Pharmaceutical compositions and methods of use of salicylanilides for treatment of hepatitis viruses
SG176045A1
Haloalkyl heteroaryl benzamide compounds
EP2178852A1
Alkylsulfonyl-substituted thiazolide compounds
ZA200806310B
Viral hepatitis treatment
US2007015803A1
Methods for treating diseases through interruption of protein maturation, compounds that inhibit the function of molecular chaperones such as protein disulfide isomerases or interfere with glycosylation, pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents
WO2006042195A1
Alkyl benzamides
CN101035531A
Halogenated benzamide derivatives
AU5785901A
Pharmaceutical compositions of tizoxanide and nitazoxanide
US5925622A
Synthesis of aryl glucuronide of 2-hydroxy-N- (5-nitro-2-thiazolyl) benzamide, and pharmaceutical compositions comprising same
BR9808722A
Pharmaceutical compositions of tizoxanide and nitazoxanide
US5935591A
Method for treatment of equine protozoal myeloencephalitis with thiazolides
US5965590A
Method for treatment of opportunistic infections with pharmaceutical compositions of tizoxanide and nitazoxanide
US5856348A
Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide
US5968961A
Pharmaceutical compositions of tizoxanide and nitazoxanide
US5859038A
Method for treatment of helicobacter pylori infections
